logo-loader

AcelRx Pharmaceuticals

Receive alerts
Market:
NASDAQ
Market Cap:
$134.48 m
Price
1.69 USD
Change
-3.43%
52 weeks high
4.09
52 weeks low
1.68

In brief

AcelRx Pharmaceuticals is a development-stage specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of acute pain. The Company's lead product candidate, Zalviso, is intended for the management of moderate-to-severe acute pain in hospitalized adult patients.